Cardiothoracic & vascular anesthesia

Alterations in Total and Unbound Remimazolam Concentrations During Cardiac Surgery Requiring Cardiopulmonary Bypass: A Single-center Observational Study

J Cardiothorac Vasc AnesthPublished Prospective observational study

Authors' conclusion

An increase in unbound concentration and a transient decrease in total concentration occurred at CPB initiation. Under the present dosing protocol, unbound remimazolam concentrations remained elevated throughout surgery.

Study context

Population
Adults aged ≥20 years, weighing ≤90 kg, undergoing elective cardiac surgery with cardiopulmonary bypass (CPB), receiving remimazolam 12 mg·kg⁻¹·h⁻¹ until loss of responsiveness then 1 mg·kg⁻¹·h⁻¹
Exposure
T1 vs T3
Outcome
Total and unbound remimazolam concentrations
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Total concentration T1 vs T3: median 761 vs 560 ng·mL⁻¹ (significantly lower at T3)
p < 0.001
Unbound concentration T1 vs T3: median 7.1 vs 23.5 ng·mL⁻¹ (significantly higher at T3)
p < 0.001

Observational data: associations, not effects.

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Alterations in Total and Unbound Remimazolam Concentrations During Cardiac Surgery Requiring Cardiopulmonary Bypass: A Single-center Observational Study. J Cardiothorac Vasc Anesth. Published 26 December 2025. doi:10.1053/j.jvca.2025.12.025

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.